| SC 13G/A | 2024-03-11 | T. Rowe Price Investment Management, Inc. | Black Diamond Therapeutics, Inc. | 6,675,756 | 12.9% | EDGAR |
| SC 13G | 2024-02-14 | T. Rowe Price Investment Management, Inc. | Black Diamond Therapeutics, Inc. | 3,927,879 | 7.6% | EDGAR |
| SC 13G/A | 2024-02-13 | BB BIOTECH AG | Black Diamond Therapeutics, Inc. | 8,517,839 | 16.5% | EDGAR |
| SC 13D/A | 2023-11-09 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 3,947,941 | 7.7% | EDGAR |
| SC 13G/A | 2023-02-14 | BB BIOTECH AG | Black Diamond Therapeutics, Inc. | 5,377,839 | 14.8% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Black Diamond Therapeutics, Inc. | 1,272,112 | 3.5% | EDGAR |
| SC 13G/A | 2022-04-14 | BB BIOTECH AG | Black Diamond Therapeutics, Inc. | 3,988,402 | 11.0% | EDGAR |
| SC 13G/A | 2022-02-11 | BB BIOTECH AG | Black Diamond Therapeutics, Inc. | 3,440,000 | 9.5% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | Black Diamond Therapeutics, Inc. | 1,014,791 | 2.8% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Black Diamond Therapeutics, Inc. | 2,248,467 | 6.2% | EDGAR |
| SC 13G | 2021-02-11 | BB BIOTECH AG | Black Diamond Therapeutics, Inc. | 1,900,000 | 5.3% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | Black Diamond Therapeutics, Inc. | 1,845,962 | 5.1% | EDGAR |
| SC 13D/A | 2020-12-03 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 3,947,941 | 11.0% | EDGAR |
| SC 13D/A | 2020-11-23 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 4,933,454 | 13.7% | EDGAR |
| SC 13D/A | 2020-09-25 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 5,797,230 | 16.1% | EDGAR |
| SC 13D/A | 2020-08-21 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 6,197,230 | 17.3% | EDGAR |
| SC 13D | 2020-02-13 | New Enterprise Associates 16, L.P. | Black Diamond Therapeutics, Inc. | 3,448,757 | 9.6% | EDGAR |
| SC 13D | 2020-02-13 | Versant Venture Capital VI, L.P. | Black Diamond Therapeutics, Inc. | 6,809,414 | 19.0% | EDGAR |
| SC 13G | 2020-02-13 | Boxer Capital, LLC | Black Diamond Therapeutics, Inc. | 2,014,858 | 5.6% | EDGAR |
| SC 13D | 2020-02-05 | RA CAPITAL MANAGEMENT, L.P. | Black Diamond Therapeutics, Inc. | 2,589,904 | 7.2% | EDGAR |